Surya Pharmaceutical reports net loss of Rs 88.11 crore in the September 2013 quarter

Sales decline 69.97% to Rs 4.58 crore

Net Loss of Surya Pharmaceutical reported to Rs 88.11 crore in the quarter ended September 2013 as against net loss of Rs 78.00 crore during the previous quarter ended September 2012. Sales declined 69.97% to Rs 4.58 crore in the quarter ended September 2013 as against Rs 15.25 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales4.5815.25 -70 OPM %-69.00-122.10 -PBDT-72.44-68.99 -5 PBT-88.11-78.00 -13 NP-88.11-78.00 -13

Powered by Capital Market - Live News